JANELLE AUYANG: Open Payments
NPI 1508333733 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 26 payments from 8 companies in 2025. Trend: 2023 $952 · 2024 $1,249 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $292 |
| ABBVIE INC. | 10 | $170 |
| Galderma Laboratories, L.P. | 5 | $94 |
| Arcutis Biotherapeutics, Inc. | 2 | $32 |
| Amgen Inc. | 2 | $30 |
| GENZYME CORPORATION | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Blueprint Medicines Corporation | 1 | $21 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, AYVAKIT, Zoryve, OTEZLA, Rhapsido, RYBREVANT.
Industry payments across NY — which companies pay providers there.
